Indications - KVR Pharmaceuticals

BIPAZEN^TM (desmopressin acetate injection) is indicated for:

prophylaxis of mild hemophilia A, and
mild von Willebrand’s disease Type I

Hemophilia A

BIPAZEN^TM is indicated for patients with hemophilia A with Factor VIII levels greater than 5%.

BIPAZEN^TM will stop bleeding in hemophilia A patients with episodes of spontaneous or trauma-induced injuries such as hemarthroses, intramuscular hematomas or mucosal bleeding. In certain clinical situations, it may be justified to try BIPAZEN^TM in patients with Factor VIII levels between 2-5%, however, these patients should be carefully monitored.

BIPAZEN^TM will often maintain hemostasis in patients with hemophilia A during surgical procedures and postoperatively.

Von Willebrand’s Disease (Type I)

BIPAZEN^TM is indicated for patients with mild to moderate classic von Willebrand’s Disease (Type I) with Factor VIII levels greater than 5%.

BIPAZEN^TM will usually stop bleeding in mild to moderate von Willebrand’s patients with episodes of spontaneous or trauma-induced injuries such as hemarthroses, intramuscular hematomas or mucosal bleeding.